Back to insights
OneVentures

Vaxxas recognised as Janssen Ausbiotech Emergeing Company of the Year 2012

Read more

Related insights

10 June 2023

Healthcare

Biotech ImmVirX bucks VC desert to bank raise at $75m valuation

Read the full article: Australian Financial Review
afr.com/technology/biotech-immvirx-bucks-vc-desert-to-bank-raise-at-75m-valuation-20230604-p5ddrw

18 June 2023

Healthcare

Vaxxas opens world-class manufacturing facility to produce needle-free vaccine patch

Read the full article: Vaxxas
businesswire.com/news/home/20230618635444/en/Vaxxas-Opens-World-Class-Manufacturing-Facility-To-Produce-Proprietary-Needle-Free-Vaccine-Patch-For-Late-Stage-Clinical-Trials-and-First-Commercial-Products

10 November 2021

Healthcare

Vaxxas recognised in the Top 10 healthcare startups in Australia, 2021

Read the full article: Startup Lanes
www-startuplanes-com.cdn.ampproject.org/c/s/www.startuplanes.com/top-10-healthcare-startups-in-australia/amp/

View all